Zobrazeno 1 - 10
of 146
pro vyhledávání: '"B Hazleman"'
Autor:
J. Wotjulewski, Coppock Js, T. J. Daymond, D. L. Scott, Hedley Berry, L. Fernandes, B. Hazleman, F. Nichol, Ali S M Jawad, Anthony D. Woolf, R W Jubb, M. Webley, P. McGill, J. Palit, David V. Doyle, Hilary A Capell, J. Hunter, E. C. Huskisson, T. Kennedy
Publikováno v:
Rheumatology. 39:1095-1101
Background Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used to treat osteoarthritis (OA), though their long-term efficacy is uncertain. We report a comparison of the symptomatic responses to therapy with tiaprofenic acid, indomethacin a
Publikováno v:
The Practitioner. 245(1624)
Autor:
B, Hazleman
Publikováno v:
Clinical and experimental rheumatology. 18(4 Suppl 20)
The most useful investigation in supporting the clinical diagnosis of PMR/GCA is elevation of the erythrocyte sedimentation rate (ESR) or viscosity. Acute phase proteins, particularly CRP, are also elevated but in most cases are not more helpful than
Publikováno v:
Clinical and experimental rheumatology. 13(5)
PMR/GCA is a relatively common inflammatory disease in the elderly population. Clinical differentiation from a polymyalgic onset of RA in the elderly can be difficult. We have examined in a preliminary study the hypothesis that serum cytidine deamina
Publikováno v:
The Journal of rheumatology. 22(9)
To determine the incidence of elevated levels of anticardiolipin antibody (aCL) in patients with newly diagnosed polymyalgia rheumatica (PMR) and/or giant cell arteritis (GCA); and to determine the relationship between these antibodies at diagnosis a
Autor:
Robert M. Bernstein, B Hazleman
Publikováno v:
Current medical research and opinion. 13(2)
An open label study was carried out to assess the long-term use of acemetacin in patients suffering from rheumatoid arthritis. One hundred and two patients were treated with acemetacin, some patients for up to a 12-month period. Analysis of efficacy
1. Calcitonin gene related peptide (CGRP) is a potent endogenous vasodilator to which we have previously demonstrated a specific hypersensitivity in skin blood flow in the hands in patients with Raynaud's disease. 2. We have now investigated whether
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bd3627cd5ff9dcd4fd927e0058331e3
https://europepmc.org/articles/PMC1368445/
https://europepmc.org/articles/PMC1368445/
Autor:
B, Hazleman
Publikováno v:
British journal of rheumatology. 30(1)
Autor:
B, Hazleman
Publikováno v:
British journal of rheumatology. 29(5)
Autor:
B, Hazleman
Publikováno v:
British journal of rheumatology. 29(2)